Core Insights - The article highlights the significant net inflow of main funds into various stocks, with a total of 94 stocks experiencing a net inflow for five consecutive days or more as of November 11 [1] Group 1: Main Fund Inflows - Han's Meditech (寒武纪-U) leads with a continuous net inflow for 54 days, totaling 6.722 billion yuan [1] - Industrial and Commercial Bank of China (工商银行) follows with a net inflow of 1.225 billion yuan over 7 days [1] - The top stocks by net inflow days include: - Han's Meditech (54 days) - CITIC Bank (中信银行) (10 days) - China Communications Construction (交通银行) (8 days) [1] Group 2: Performance Metrics - Han's Meditech (寒武纪-U) has a cumulative increase of 42.40% during the inflow period [1] - Huazhong City A (华侨城A) shows a significant increase of 22.08% over the last 6 days [1] - Other notable performers include: - Wanhua Chemical (万华化学) with a 10.31% increase - China Film (中国电影) with a 34.51% increase [1] Group 3: Fund Inflow Proportions - Huazhong City A (华侨城A) has the highest proportion of net inflow to trading volume at 15.29% [1] - Other stocks with notable inflow proportions include: - Shenzhou Digital (神州数字) at 8.05% - CITIC Bank (中信银行) at 12.50% [1]

Market Overview - On November 11, the software development sector declined by 1.82%, with Fangzhi Technology leading the drop [1] - The Shanghai Composite Index closed at 4002.76, down 0.39%, while the Shenzhen Component Index closed at 13289.0, down 1.03% [1] Stock Performance - Notable gainers in the software development sector included: - Anbotong (688168) with a closing price of 95.37, up 7.98% [1] - Pinming Technology (688109) at 144.89, up 4.64% [1] - Zhongdian Xilong (002298) at 12.93, up 4.61% [1] - Major decliners included: - Fangzhi Technology (300235) at 16.56, down 9.06% [2] - Zhinanzhen (300803) at 124.60, down 6.90% [2] - Geer Software (603232) at 24.11, down 6.26% [2] Capital Flow - The software development sector experienced a net outflow of 4.044 billion yuan from institutional investors, while retail investors saw a net inflow of 2.892 billion yuan [2] - The sector's overall capital flow indicates a mixed sentiment among different investor types [2] Individual Stock Capital Flow - Daily Interactive (300766) had a net inflow of 200 million yuan from institutional investors, while it faced a net outflow of 60.2548 million yuan from speculative funds [3] - Zhongdian Xilong (002298) saw a net inflow of 173 million yuan from institutional investors, with a net outflow of 61.9022 million yuan from speculative funds [3] - Anbotong (688168) had a net inflow of 33.35 million yuan from institutional investors, but faced a net outflow of 24.4317 million yuan from speculative funds [3]

证券代码：688168 证券简称：安博通 公告编号：2025-038 北京安博通科技股份有限公司 关于实际控制人所持公司部分股票将被司法拍卖 的进展公告 （一）拍卖标的：钟竹持有的公司 220,000 股股票（证券名称：安博通，证 券代码：688168，证券性质：无限售流通股）。 1、拍卖时间：2025 年 12 月 8 日 10 时至 2025 年 12 月 9 日 10 时止（延时 除外） 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 钟竹先生直接持有北京安博通科技股份有限公司（以下简称"公司"） 股份比例为 23.69%，一致行动人石河子市崚盛股权投资合伙企业（有限合伙） （以下简称"崚盛投资"）持有公司股份比例为 11.33%，钟竹先生与一致行动 人崚盛投资合计持有公司股份比例为 35.02%。截至本公告披露日，本次实际控 制人钟竹先生直接持有的公司 220,000 股股票将被司法拍卖，占公司总股本比例 为 0.29%。 ● 受让股份锁定期：六个月；被拍卖股份为公司控股股东、实际控制人所 持有 ...

Group 1 - The core point of the news is that Anbotong's stock price has decreased by 5.1%, currently trading at 77.27 yuan per share, with a total market capitalization of 5.939 billion yuan [1] - Anbotong Technology Co., Ltd. specializes in the research, development, sales, and related technical services of core software products in the cybersecurity industry, providing security system platforms and services [1] - The company's main revenue sources are: Security Gateway (39.47%), Security Artificial Intelligence (35.21%), Security Management (18.05%), Security Services (7.15%), and Others (0.12%) [1] Group 2 - According to data, one fund under GF Fund holds a significant position in Anbotong, specifically the GF Reform Mixed Fund, which has maintained its holding of 68,900 shares, accounting for 2.31% of the fund's net value [2] - The GF Reform Mixed Fund has a total scale of 233 million yuan and has achieved a year-to-date return of 28.65%, ranking 3217 out of 8150 in its category [2] - The fund manager, Chen Shaoping, has a tenure of 18 years and 344 days, with the best fund return during his tenure being 73.66% and the worst being -27.18% [2]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 北京安博通科技股份有限公司（以下简称"公司"）董事会于 2025 年 9 月 25 日召开了第三届董事会第十八次会议，审议通过了《关于聘任公司董事会秘 书的议案》。经公司董事长提名，董事会提名委员会对被提名人资格审查通过， 董事会同意聘任刘磊先生为公司董事会秘书，具体详见公司于 2025 年 9 月 26 日发布的《关于聘任董事会秘书的公告》（公告编号：2025-031）。 目前刘磊先生已考核合格并获得了由上海证券交易所颁发的科创板《董事会 秘书任职培训证明》，符合《上海证券交易所科创板股票上市规则》规定的董事 会秘书任职资格。刘磊先生自取得科创板《董事会秘书任职培训证明》起正式履 行职责，其任期自取得董秘资格证书起至本届董事会任期届满为止。 刘磊先生联系方式如下： 证券代码：688168 证券简称：安博通 公告编号：2025-037 电子邮箱：xiazf@abtnetworks.com 北京安博通科技股份有限公司 关于董事会秘书正式履职的公告 北京安博通科技股份有限公司董事 ...

Core Viewpoint - Anbotong, a leading company in the domestic cybersecurity core software sector, has faced challenges in revenue and net profit despite a strong market position and high gross margins [1][3]. Group 1: Company Overview - Anbotong was established on May 25, 2007, and listed on the Shanghai Stock Exchange on September 6, 2019, with its headquarters in Beijing [1]. - The company focuses on the research, development, sales, and related technical services of cybersecurity core software products, positioning itself as a provider of cybersecurity system platforms and services [1]. Group 2: Financial Performance - In Q3 2025, Anbotong achieved a revenue of 500 million yuan, ranking 22nd out of 35 in the industry, significantly lower than the top competitor, iFlytek, which reported 16.989 billion yuan [2]. - The net profit for the same period was -145 million yuan, placing the company 26th in the industry, with losses exceeding the industry average of -98.147 million yuan [2]. Group 3: Profitability and Debt - Anbotong's debt-to-asset ratio stood at 29.42% in Q3 2025, an increase from 23.89% year-on-year, aligning with the industry average [3]. - The gross margin for Q3 2025 was 83.24%, a significant increase from 60.70% year-on-year, surpassing the industry average of 63.59% [3]. Group 4: Executive Compensation - The chairman and CEO, Zhong Zhu, received a salary of 3.9175 million yuan in 2024, an increase of 1.8615 million yuan from 2023 [4]. Group 5: Shareholder Information - As of September 30, 2025, the number of A-share shareholders increased by 25.39% to 6,479, while the average number of circulating A-shares held per account decreased by 20.25% to 11,900 [5]. - The company reported significant revenue growth in the first half of 2025, primarily driven by a surge in its AI security business, although profit margins were pressured by increased sales expenses [5].

Core Points - The Shanghai Composite Index closed at 3961.62 points, above the six-month moving average, with a decline of 0.63% [1] - The total trading volume of A-shares reached 157.92 billion yuan [1] - A total of 259 A-shares have surpassed the six-month moving average, with notable stocks showing significant deviation rates [1] Summary by Category Market Performance - The Shanghai Composite Index is currently at 3961.62 points, indicating a slight decline of 0.63% [1] - The total trading volume for A-shares today is reported at 157.91 billion yuan [1] Stocks Surpassing Six-Month Moving Average - 259 A-shares have broken through the six-month moving average, with the highest deviation rates observed in stocks such as: - Yatong Precision Engineering (8.20%) - Excellent New Energy (7.57%) - Deyuan Pharmaceutical (7.38%) [1] - Other stocks with smaller deviation rates include: - New Hope - Shanghai Phoenix - Angli Education, which have just crossed the six-month line [1] Notable Stocks and Their Metrics - Top stocks with significant price changes and their metrics include: - Yatong Precision Engineering: +9.76%, turnover rate 31.45%, six-month line 23.27 yuan, latest price 25.18 yuan, deviation rate 8.20% [1] - Excellent New Energy: +9.90%, turnover rate 2.44%, six-month line 45.62 yuan, latest price 49.07 yuan, deviation rate 7.57% [1] - Deyuan Pharmaceutical: +11.83%, turnover rate 8.02%, six-month line 38.03 yuan, latest price 40.84 yuan, deviation rate 7.38% [1]

Core Viewpoint - The company, Beijing Anbotong Technology Co., Ltd., has released its third-quarter report for 2025, ensuring the accuracy and completeness of the information provided in the report [2][8]. Financial Data - The financial statements for the third quarter of 2025 have not been audited [3][7]. - The report includes major accounting data and financial indicators, but specific figures are not detailed in the provided text [3][4]. Corporate Governance - The board of directors and the supervisory board have confirmed the authenticity and completeness of the quarterly report, taking legal responsibility for its content [2][8]. - The third supervisory board meeting was held on October 27, 2025, with all three supervisors present, complying with relevant regulations [9][10]. Meeting Resolutions - The supervisory board approved the proposal regarding the company's third-quarter report for 2025, with a unanimous vote of 3 in favor and no opposition [10][11].

Core Viewpoint - Anbotong (688168.SH) reported a significant decline in revenue and net profit for Q3 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company's operating revenue for Q3 2025 was 71.62 million yuan, representing a year-on-year decrease of 32.49% [1] - The net profit attributable to shareholders of the listed company was -21.33 million yuan [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -21.59 million yuan [1]

Group 1 - The core viewpoint of the news is that Ambotong (SH 688168) reported a significant increase in revenue for the third quarter of 2023, but also posted a net loss for the same period [1] - Ambotong's revenue for the first three quarters of 2023 reached approximately 500 million yuan, representing a year-on-year increase of 68.17% [1] - The net profit attributable to shareholders of the listed company was a loss of approximately 130 million yuan [1] Group 2 - As of the report, Ambotong's market capitalization stands at 6.1 billion yuan [2]